Anti-infective Drugs Market to Reach USD 169.5 Billion in 2024
Fast.MR has presented a detailed report on “Anti-infective Drugs Market - By Product Type (Anti-bacterial Drugs, Anti-fungal Drugs, and Anti-viral Drugs), By Indication (Pneumonia, Methicillin-resistant Staphylococcus Aureus, Sepsis, Tuberculosis, Dermatophytosis, Aspergillosis, Candidiasis, Hepatitis Virus Infection, HIV Infection and Respiratory Virus Infection) and By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Sales) – Global Market Analysis, Trends, Opportunity and Forecast, 2018-2024” which includes the major application, advantages, and key market trends that are fostering the growth of the market during the forecasted span of 6 years. The research takes a step forward and analyzes the key competitors and global regions that are holding the market share of Anti-infective Drugs Market in terms of revenue.
Global anti-infective drugs market is estimated to reach USD 169.5 Billion in 2024, registering a compound annual growth rate (CAGR) of 4.1% between 2019 and 2024. Growing number of anti-infection treatment and procedures is one of the key factors which is driving the growth of global anti-infective drugs market.
Get Sample Copy of This Report- https://www.fastmr.com/request-s/70
Market Insights
Growth Drivers – Anti-infective Drugs Market
Rising Penetration of Infectious Diseases
Increasing prevalence of infectious disease such as malaria, HIV, Ebola among others is expected to foster the growth of global anti-infective drugs market during the forecast period. Additionally, increasing awareness about infectious disease among people is believed to positively impact the growth of global anti-infective drugs market.
Favorable government initiatives such as awareness campaigns and reimbursement policies are also expanding the scope of growth of market players. Moreover, various companies are actively engaged in advanced drug discovery. This factor is envisioned to bolster the growth of market.
Development of New Drugs
Continuous development and innovation of new drugs is anticipated to drive the growth of global anti-infective drugs market. Some companies with Phase 3 trials such as Iterum Therapeutics, Spero Therapeutics, Nabriva Therapeutics, and Tetraphase Pharmaceuticals are likely to get approval within 12 months. This will also lead to growth of global anti-infective drugs market.
Barriers – Anti-infective Drugs Market
Anti-infective Drugs Shortages
Transient shortage and long-terms shortage of anti-infective drugs is a major growth barrier in the global anti-infective drugs market. Apart from this, various major manufacturers are shutting down their antibiotic research and development which is further likely to negative impact the growth of global anti-infective drugs market.
Segmentation Analysis
The anti-infective drugs market by product type is segmented into anti-bacterial drugs, anti-fungal drugs, and anti-viral drugs. In this segment, anti-viral drugs segment is anticipated to capture the largest market share in 2024.
Based on indication, the anti-infective drugs market is further sub segmented into pneumonia, methicillin-resistant staphylococcus aureus, sepsis, tuberculosis, dermatophytosis, aspergillosis, candidiasis, hepatitis virus infection, HIV infection and respiratory virus infection. HIV captured significant market share in overall anti-infective drugs market in 2018.
Geographical Analysis
Geographically, the report offers analysis of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In anti-infective drugs market, North America dominated in 2018, acquiring significant portion of overall market. Factors such as increasing geriatric population and presence of advanced healthcare infrastructure are some of the major factors which are believed to bolster the growth of anti-infective drugs formula in North America. Asia Pacific anti-infective drugs market is expected to showcase highest growth rate during the forecast period. Presence of generic companies and increasing spending on healthcare is anticipated to positively impact the demand for Asia Pacific anti-infective drugs market.
Competitive Analysis
The report also covers detailed competitive analysis of major market players of global anti-infective drugs market, such as Gilead Sciences, GlaxoSmithKline plc, Merck & Co, Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Boehringer Ingelheim GmbH, Pfizer, Mylan N.V., Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd and other prominent players. The anti-infective drugs market is witnessing a wide range of industry activities such as product launch, acquisition, partnership, and expansion across the globe.
Browse Complete Report With Table of Content@https://www.fastmr.com/report/70/anti-infective-drugs-market
About US:
FAST.MR is a global market research and business-consulting organization that aims to provide a deep market insight to our clients, which helps them in better decision making in the dynamic environment. We have a team of highly qualified personnel that studies the market in depth to provide our clients with better strategies to stand out in the market.
Our report covers current market status, opportunities available in the market, growth plans, and emerging trends in order to cater to the evolving needs of the customers. We help businesses around the globe with operational improvements, technologies, emerging market trends which in-depth boost the company’s growth in the future. The reports prepared by us are customized according to the client’s needs. We inculcate high morale and ethics while preparing our report which helps in building long term relationships with our clients.
Contact Us:
Jason Lee
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: sales@fastmr.com
Website: www.fastmr.com